Dryden Jack, Navas-Blanco Jose
Department of Anesthesiology, Oakland University William Beaumont School of Medicine, Corewell Health East, Royal Oak, Michigan, USA.
Saudi J Anaesth. 2025 Jul-Sep;19(3):375-383. doi: 10.4103/sja.sja_211_25. Epub 2025 Jun 16.
There is an emerging body of evidence to suggest that the peripheral administration of vasopressors is safe and effective in many clinical contexts and often superior to central administration. Vasopressors are a class of medications used to create vasoconstriction in patients with shock to increase systemic arterial blood pressure and tissue perfusion. Certain clinical circumstances require the use of these vasoactive drugs immediately for which the need to administer these drugs peripherally becomes paramount, although controversial. The authors present a narrative review dedicated to describing the current practice of the route of administration of vasopressors, comparing peripheral versus central administration, and explaining the advantages and drawbacks of each route as well as potential complications associated with them.
越来越多的证据表明,在许多临床情况下,外周给予血管升压药是安全有效的,而且往往优于中心给药。血管升压药是一类用于使休克患者血管收缩以提高体循环动脉血压和组织灌注的药物。某些临床情况需要立即使用这些血管活性药物,尽管存在争议,但在外周给予这些药物的必要性变得至关重要。作者进行了一项叙述性综述,专门描述血管升压药给药途径的当前实践,比较外周给药与中心给药,并解释每种途径的优缺点以及与之相关的潜在并发症。